Suppl table 4 |
Kopper 2019 | 49 | 45% | N/A | 3 formulations | N/A | N/A | 13 | 2 | 0.55 | 26 | 12 | 9 | 22 | 8 | 7 |
Suppl table 1 |
de Witte 2020 | 7 | 34% | N/A | 2 formulations | N/A | N/A | 4 | 0 | N/A | 3 | 1 | 1 | 5 | N/A | N/A |
Table 1 |
Maenhoudt 2020 | 27 | N/A | N/A | 4 formulations | N/A | N/A | 22 | 4 | 0.66 | 26 | 5 | 4 | 5 | N/A | N/A |
Table EV1 |
Hoffmann 2020 | 45 | N/A | N/A | 6 formulations | N/A | N/A | 13 | N/A | 0.30 | 13 | N/A | N/A | N/A | N/A | N/A |
Table 2 |
Nanki 2020 | 35 | N/A | N/A | 20 formulations | N/A | N/A | 10 | N/A | 0.90 | 9 | 15 | N/A | 13 | 3 | 3 |
Table 1 |
Maru 2019 | 15 | N/A | N/A | 2 formulations | N/A | N/A | 4 | 4 | 0.75 | 3 | 5 | 5 | 3 | 6 | 3 |
Figure 1B | Hill 2018 | N/A | N/A | N/A | 1 formulation | N/A | N/A | 21 | 9 | 1.00 | 32 | 2 | 1 | 0 | N/A | N/A |
Total | 178 | 40% | | | | | 87 | 19 | 0.71 | 112 | 40 | 20 | 48 | 17 | 13 |
| | | | | | | | | 0.22 | | | | 0.50 | | | |
UTERINE CANCER | | | | | | | | | | | | |
| |
Total_Recruited |
Tumor_content |
Viability |
Formulations_tested |
Randomisation |
Blinding |
Success_rate |
G1 endometrioid |
G2 endometrioid |
G3 endometrioid |
serous |
Other |
Lynch_syndrom |
MOLECULAR_CLASSES |
Suppl Table 1 |
Boretto 2019 | 16 | N/A | N/A | 2 formulations | N/A | N/A | 0.42 | 8 | 3 | 0 | 3 | 2 | 1 | N/A | |
Suppl Table 1 |
Turco 2017 | 3 | N/A | N/A | 1 formulation | N/A | N/A | N/A | 1 | 1 | 0 | 1 | N/A | N/A | N/A | |
Table 1 |
Girda 2017 | 15 | N/A | N/A | 1 formulation | N/A | N/A | N/A | 7 | 3 | 5 | 0 | N/A | N/A | N/A | |
Table 1 |
Maru 2019 | 6 | N/A | N/A | 2 formulations | N/A | N/A | 0.83 | 2 | 2 | 1 | 0 | 1 | N/A | N/A | |
Total | 40 | | | | | | 0.63 | 18 | 9 | 6 | 4 | 3 | 1 | N/A | |
| | | | | | | | | | | | | | | | |
CERVICAL CANCER | | | | | | | | | | | | |
| |
Total_Recruited |
Tumor_content |
Viability |
Formulations_tested |
Randomisation |
Blinding |
SCC |
Organoid_outgrowth |
Efficiency |
AdenoCa |
Organoid_outgrowth |
Efficiency | | |
Table S1 |
Lõhmussaar 2021 | 26 | N/A | N/A | 7 formulations + withdrawal test | N/A | N/A | 22 | 11 | 0.50 | 4 | 1 | 0.25 | | | |